1064662-40-3
1064662-40-3 结构式
基本信息
中文别名
化合物 T12944 英文别名
SNT-207707FBNJDWPWZNPVSC-UHFFFAOYSA-N
IMidazo[1,2-a]pyridine-6-carboxaMide, 2-(4-cyanophenyl)-N,N-bis(3-Methylbutyl)-3-[3-(1-pyrrolidinyl)propyl]-, hydrochloride (1:1)
物理化学性质
储存条件-20°C储存
溶解度DMSO: ≥ 250 mg/mL (454.40 mM); Methanol: 250 mg/mL (454.40 mM)
形态Solid
颜色White to off-white
SNT-207707价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2025/05/22 | HY-11029 | SNT-207707 | 1064662-40-3 | 1 mg | 1170元 |
| 2025/05/22 | HY-11029 | SNT-207707 SNT-207707 | 1064662-40-3 | 5mg | 3200元 |
| 2025/05/22 | HY-11029 | SNT-207707 SNT-207707 | 1064662-40-3 | 10mM * 1mLin DMSO | 3873元 |
常见问题列表
生物活性
SNT-207707是一种有效，选择性，有口服活性的黑素皮质素受体 (melanocortin MC-4) 拮抗剂，IC50 值为8 nM (结合) 和5 nM (功能)。靶点
IC50: 8 nM (binding MC-4), 5 nM (function MC-4)
体外研究
SNT-207707 binds to the MC-4 receptor with an affinity of 8 nM and shows a more than 200-fold selectivity vs. MC-3 and MC-5. SNT207858 is a 22 nM MC-4 antagonist with a 170-fold selectivity vs. MC-3 and a 40-fold selectivity versus MC-5.
体内研究
Single subcutaneous injection of 20 mg/kg of SNT-207707 distinctly increases food intake of the mice. Once daily oral administration of both compounds SNT207858 and SNT-207707 starting the day after tumor implantation significantly reduces the tumor induced weight loss.